A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy

• Main Authors: Eun-Seok Jeon (Author), Sang Wook Lim (Author), Seok-Yeon Kim (Author), Hyoung-Mo Yang (Author), Moo Hyun Kim (Author), Moo-Yong Rhee (Author), Seung Hwan Han (Author), Jinho Shin (Author), Kwang-il Kim (Author), Jin-Ok Jeong (Author), Ki Chul Sung (Author), Geu Ru Hong (Author), Hyung-Seop Kim (Author), Kihwan Kwon (Author), Tae-Soo Kang (Author), Hae-Young Lee (Author), Su-Eun Han (Author)
• Format: Book
• Published: BMC, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background To assess the efficacy and safety of a combination therapy involving fimasartan, amlodipine, and rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond to fimasartan monotherapy. Methods This phase III, randomized, double-blind, multicenter stud...